FDA Approves Pharmaxis’ ARIDOL™ (Mannitol Inhalation Powder) Bronchial … – Kansas City Star

FDA Approves Pharmaxis' ARIDOL™ (Mannitol Inhalation Powder) Bronchial
Kansas City Star
ARIDOL is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma.

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.